A simple tool to help others understand those living with dementia
By
Angie Frantz
Jul 25, 2022
I recently had the honor of attending the Alzheimer’s Disease International 2022 Global Conference in London, where I presented about a memory care initiative that we’ve been rolling out across Prestige...
U.S. News launches ‘Best Senior Living’ program
By
Lois A. Bowers
Sep 07, 2021
U.S. News & World Report has launched a “Best Senior Living” initiative with the goal of releasing inaugural listings for consumers in the first quarter of 2022. The program will cover individual...
Medicare policy changes tied to drop in hospice use for dementia
May 09, 2022
Immediate and lasting reductions were seen in the share of patients receiving hospice care with the Alzheimer’s disease and related dementia code.
Senior living braces for changes in 2020 as top challenges remain
By
Lois A. Bowers
Jan 02, 2020
As 2020 begins, the senior living industry is preparing for the changing needs and wants of current and future residents as workforce and occupancy issues continue to challenge operators, according to...
Assisted living liability claim costs continue to top skilled nursing costs: report
By
Kimberly Bonvissuto
Mar 18, 2022
The average cost of liability claims across all aging services settings has increased since 2018, with assisted living claim costs continuing to exceed those in skilled nursing, according to a new report...
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
Modern technology’s positive effects on memory care
By
Tom Rotz
Apr 18, 2016
Advancements in technology can have a positive effect on memory care and those affected, by improving quality of life and even slowing the progression of the disease.
Pfizer to end Alzheimer’s, Parkinson’s research
By
Lois A. Bowers
Jan 09, 2018
Pharmaceutical company Pfizer has announced that it will end its research and development programs for Alzheimer’s and Parkinson’s treatments and “re-allocate funding to those areas where...
Alzheimer’s disease in Down syndrome similar to autosomal dominant form
May 25, 2022
Age at onset and mortality for Alzheimer’s disease in people with Down syndrome were comparable with fully penetrant form of the disease.
Investing in people, innovation, efficiencies makes senior living better: panel
By
Kimberly Bonvissuto
Sep 16, 2022
WASHINGTON, DC — A panel of senior living CEOs took the theme of the 2022 National Investment Center for Seniors Housing & Care Fall Conference to heart as they discussed how the industry needs to move...